Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms

References

• KinaneDFStathopoulouPGPapapanouPNPeriodontal diseasesNat Rev Dis Primers201731703828805207
   PubMed Web of Science ®Google Scholar
• TonettiMSJepsenSJinLOtomo-CorgelJImpact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: a call for global actionJ Clin Periodontol201744545646228419559
   PubMed Web of Science ®Google Scholar
• KhanSAKongEFMeillerTFJabra-RizkMAPeriodontal diseases: bug induced, host promotedPLoS Pathog2015117e100495226226364
   PubMed Web of Science ®Google Scholar
• YorkABiofilms: the architect of the biofilmNat Rev Microbiol20171511642643
   PubMed Web of Science ®Google Scholar
• WuHMoserCWangHZHøibyNSongZJStrategies for combating bacterial biofilm infectionsInt J Oral Sci2015711725504208
   PubMed Web of Science ®Google Scholar
• FerrerMDMiraAOral biofilm architecture at the microbial scaleTrends Microbiol201624424624826962018
   PubMed Web of Science ®Google Scholar
• Vieira ColomboAPMagalhãesCBHartenbachFAMartins do SoutoRMaciel da Silva-BoghossianCPeriodontal-disease-associated biofilm: a reservoir for pathogens of medical importanceMicrob Pathog201694273426416306
   PubMed Web of Science ®Google Scholar
• KleinMIHwangGSantosPHCampanellaOHKooHStreptococcus mutans-derived extracellular matrix in cariogenic oral biofilmsFront Cell Infect Microbiol201551025763359
   PubMed Web of Science ®Google Scholar
• KrethJZhangYHerzbergMCStreptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutansJ Bacteriol2008190134632464018441055
   PubMed Web of Science ®Google Scholar
• XiaoJHaraATKimDZeroDTKooHHwangGBiofilm three-dimensional architecture influences in situ pH distribution pattern on the human enamel surfaceInt J Oral Sci201792747928452377
   PubMed Web of Science ®Google Scholar
• LebeauxDGhigoJMBeloinCBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibioticsMicrobiol Mol Biol Rev201478351054325184564
   PubMed Web of Science ®Google Scholar
• MahTFO’TooleGAMechanisms of biofilm resistance to antimicrobial agentsTrends Microbiol200191343911166241
   PubMed Web of Science ®Google Scholar
• PercivalSLMcCartySMSilver and alginates: role in wound healing and biofilm controlAdv Wound Care (New Rochelle)20154740741426155383
   PubMed Web of Science ®Google Scholar
• AbdulkareemEHMemarzadehKAllakerRPHuangJPrattenJSprattDAnti-biofilm activity of zinc oxide and hydroxyapatite nanoparticles as dental implant coating materialsJ Dent201543121462146926497232
   PubMed Web of Science ®Google Scholar
• JonesCGChlorhexidine: is it still the gold standard?Periodontol 2000199715155629643233
   PubMedGoogle Scholar
• HopeCKWilsonMAnalysis of the effects of chlorhexidine on oral biofilm vitality and structure based on viability profiling and an indicator of membrane integrityAntimicrob Agents Chemother20044851461146815105093
   PubMed Web of Science ®Google Scholar
• ShenYStojicicSHaapasaloMAntimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of developmentJ Endod201137565766121496666
   PubMed Web of Science ®Google Scholar
• RizzelloLPompaPPNanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelinesChem Soc Rev20144351501151824292075
   PubMed Web of Science ®Google Scholar
• FranciGFalangaAGaldieroSSilver nanoparticles as potential antibacterial agentsMolecules20152058856887425993417
   PubMed Web of Science ®Google Scholar
• SinghPPanditSGarnæsJGreen synthesis of gold and silver nanoparticles from Cannabis sativa (industrial hemp) and their capacity for biofilm inhibitionInt J Nanomedicine2018133571359129950836
   PubMed Web of Science ®Google Scholar
• MonteiroDRSilvaSNegriMAntifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilmsMycoses201356667268023773119
   PubMed Web of Science ®Google Scholar
• Ben-KnazRPedahzurRAvnirDBioactive doped metals: high synergism in the bactericidal activity of chlorhexidine@silver towards wound pathogenic bacteriaRSC Adv201332180098015
   Web of Science ®Google Scholar
• SupranotoSCSlotDEAddyMVan der WeijdenGAThe effect of chlorhexidine dentifrice or gel versus chlorhexidine mouthwash on plaque, gingivitis, bleeding and tooth discoloration: a systematic reviewInt J Dent Hyg2015132839225059640
   PubMed Web of Science ®Google Scholar
• SongYLiYXuQLiuZMesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlookInt J Nanomedicine2017128711028053526
   PubMed Web of Science ®Google Scholar
• KangTLiFBaikSShaoWLingDHyeonTSurface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapyBiomaterials20171369811428525855
   PubMed Web of Science ®Google Scholar
• YangKFengLLiuZStimuli responsive drug delivery systems based on nano-graphene for cancer therapyAdv Drug Deliv Rev2016105Pt B22824127233212
   PubMed Web of Science ®Google Scholar
• ZhengXZhangFZhaoYSelf-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranosticsTheranostics20188143808382330083261
   PubMed Web of Science ®Google Scholar
• BhartiCNagaichUPalAKGulatiNMesoporous silica nanoparticles in target drug delivery system: a reviewInt J Pharm Investig201553124133
   PubMed Web of Science ®Google Scholar
• ShaoDLiJZhengXJanus “nano-bullets” for magnetic targeting liver cancer chemotherapyBiomaterials201610011813327258482
   PubMed Web of Science ®Google Scholar
• ShaoDLuMMZhaoYWThe shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistributionActa Biomater20174953154027836804
   PubMed Web of Science ®Google Scholar
• WangZChangZLuMJanus silver/silica nanoplatforms for light-activated liver cancer chemo/photothermal therapyACS Appl Mater Interfaces2017936303063031728836433
   PubMed Web of Science ®Google Scholar
• WangZShaoDChangZJanus gold nanoplatform for synergetic chemoradiotherapy and computed tomography imaging of hepatocellular carcinomaACS Nano20171112127321274129140684
   PubMed Web of Science ®Google Scholar
• WangZChangZLuMShape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinomaBiomaterials201815414715729128843
   PubMed Web of Science ®Google Scholar
• ChangZMWangZShaoDShape engineering boosts magnetic mesoporous silica nanoparticle-based isolation and detection of circulating tumor cellsACS Appl Mater Interfaces20181013106561066329468874
   PubMed Web of Science ®Google Scholar
• WangY-SShaoDZhangLGold nanorods-silica Janus nanoparticles for theranosticsAppl Phys Lett201510617173705
   Web of Science ®Google Scholar
• KuthatiYKankalaRKLinSXWengCFLeeCHpH-triggered controllable release of silver-indole-3 acetic acid complexes from mesoporous silica nanoparticles (IBN-4) for effectively killing malignant bacteriaMol Pharm20151272289230425996616
   PubMedGoogle Scholar
• ChangZMWangZLuMMJanus silver mesoporous silica nanobullets with synergistic antibacterial functionsColloids Surf B Biointerfaces201715719920628595136
   PubMed Web of Science ®Google Scholar
• ShaoDWangZDongWFFacile synthesis of core–shell magnetic mesoporous silica nanoparticles for pH-sensitive anticancer drug deliveryChem Biol Drug Des20158661548155326216620
   PubMed Web of Science ®Google Scholar
• ChangZ-MWangZShaoDFluorescent-magnetic Janus nanorods for selective capture and rapid identification of foodborne bacteriaSens Actuators B Chem201826010041011
   Web of Science ®Google Scholar
• Şen KaramanDMannerSRosenholmJMMesoporous silica nanoparticles as diagnostic and therapeutic tools: how can they combat bacterial infection?Ther Deliv20189424124429495945
   PubMed Web of Science ®Google Scholar
• CroissantJGFatieievYKhashabNMDegradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticlesAdv Mater Epub1312017
   PubMed Web of Science ®Google Scholar
• YueJLuoSZLuMMShaoDWangZDongWFA comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapyChem Biol Drug Des20189221435144429671941
   PubMed Web of Science ®Google Scholar
• ShaoDLiMWangZBioinspired diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein deliveryAdv Mater2018301801198
   Web of Science ®Google Scholar
• duXLiXXiongLZhangXKleitzFQiaoSZMesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent deliveryBiomaterials2016919012727017579
   PubMed Web of Science ®Google Scholar
• duXKleitzFLiXHuangHZhangXQiaoSZDisulfide-bridged organosilica frameworks: designed, synthesis, redox-triggered biodegradation, and nanobiomedical applicationsAdv Funct Mater Epub2542018
   PubMed Web of Science ®Google Scholar
• LuMMWangQJChangZMSynergistic bactericidal activity of chlorhexidine-loaded, silver-decorated mesoporous silica nanoparticlesInt J Nanomedicine2017123577358928533681
   PubMed Web of Science ®Google Scholar
• ZhongLPPanHYZhouXJCharacteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell lineArch Oral Biol200853544345218206853
   PubMed Web of Science ®Google Scholar
• MüllerHDEickSMoritzALussiAGruberRCytotoxicity and antimicrobial activity of oral rinses in vitroBiomed Res Int20172017401972328401154
   PubMed Web of Science ®Google Scholar
• GailletSRouanetJMSilver nanoparticles: their potential toxic effects after oral exposure and underlying mechanisms – a reviewFood Chem Toxicol201577586325556118
   PubMed Web of Science ®Google Scholar